These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I). Herrman JP; Hermans WR; Vos J; Serruys PW Drugs; 1993 Jul; 46(1):18-52. PubMed ID: 7691506 [TBL] [Abstract][Full Text] [Related]
15. Prevention of restenosis after angioplasty. Cahill MR; Macey MG; Dawson JR; Newland AC Lancet; 1994 May; 343(8909):1361. PubMed ID: 7910347 [No Abstract] [Full Text] [Related]
16. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. Ip JH; Fuster V; Israel D; Badimon L; Badimon J; Chesebro JH J Am Coll Cardiol; 1991 May; 17(6 Suppl B):77B-88B. PubMed ID: 2016486 [TBL] [Abstract][Full Text] [Related]
17. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a "magic bullet". Hermans WR; Rensing BJ; Strauss BH; Serruys PW Am Heart J; 1991 Jul; 122(1 Pt 1):171-87. PubMed ID: 2063736 [No Abstract] [Full Text] [Related]
18. [Platelet membrane glycoproteins as site of pharmacological intervention in the treatment of coronary disease]. Neumann FJ; Gawaz M; Schömig A Dtsch Med Wochenschr; 1997 Oct; 122(40):1224-30. PubMed ID: 9378047 [No Abstract] [Full Text] [Related]
19. A mainstay drug underperforms. But a bedside test makes it easier to spot "aspirin resistance". Heart Advis; 2004 Aug; 7(8):3. PubMed ID: 15551431 [No Abstract] [Full Text] [Related]
20. Preventing coronary restenosis and complications. Holmes DR N Engl J Med; 1997 Jun; 336(24):1748-9. PubMed ID: 9180094 [No Abstract] [Full Text] [Related] [Next] [New Search]